🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is evaluating the reactivation of BK virus in patients ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2018-07-30
Trial ID
NCT03532971
Treatments Being Tested
This study is a phase 2, multicenter, randomized controlled trial to test t...
Status
Not Yet Recruiting
Location
University of Kansas Cancer Center
Start Date
2026-05
Trial ID
NCT07516314
Treatments Being Tested
This pilot clinical trial studies the side effects and best dose of ruxolit...
Status
Completed
Location
City of Hope Medical Center
Start Date
2016-11-13
Trial ID
NCT02917096
Patients who have measurable residual disease (MRDpos, defined as MRD \> 0....
Status
Withdrawn
Location
NL-Amsterdam-VUMC
Start Date
2022-01
Trial ID
NCT05063123
Treatments Being Tested
The purposes of the study are to determine the maximum tolerated dose (MTD)...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2022-03-21
Trial ID
NCT05015426
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled clinical trial of Fe...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2019-09-09
Trial ID
NCT03678493
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This is a Phase III, randomized, unblinded, multicenter, prospective compar...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2011-01
Trial ID
NCT01278927
Treatments Being Tested
This phase II clinical trial studies how well treosulfan, thiotepa, fludara...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-05-05
Trial ID
NCT03980769
This is a prospective, single-arm, phase II study. Patients will be treated...
Status
Recruiting
Location
Chao Family Comprehensive Cancer Center, University of California Irvine
Start Date
2023-09-11
Trial ID
NCT06028828
Treatments Being Tested